Envista Holdings Corp (NVST)
| Market Cap | $3.73B+25.3% |
| Revenue (ttm) | $2.88B |
| Net Income | $633.60M |
| EPS | $3.85 |
| Shares Out | 160.34M |
| PE Ratio | 6.04 |
| Forward PE | 13.91 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,450,892 |
| Open | $23.75 |
| Previous Close | $23.75 |
| Day's Range | $23.02 - $23.76 |
| 52-Week Range | $18.89 - $30.42 |
| Beta | 0.94 |
| Analysts | Buy |
| Price Target | $28.92(+24.29%) |
| Earnings Date | Feb 3, 2027 |
About NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
8 firms rating NVST in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 3, 2027Earnings report
$NVST stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of NVST by members of U.S. Congress
| Pete SessionsHouse / R | Sale$1.00K – $15.00K | Jun 6, 2024 |
Recently reported changes in NVST holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NVST's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NVST Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NVST Revenue by Segment or Geography
| Corporate and other | $1.20B | 49.79% |
| Operating profit | $515.20M | 21.44% |
| Specialty Products & Technologies | $443.70M | 18.46% |
| Equipment & Consumables | $247.80M | 10.31% |
As of: Q4 2026 (Oct 2, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New NVST patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NVST from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NVST’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat with guidance raise outweighed by analyst downgrades; mixed business momentum signals underlying uncertainty.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| SAEF | Schwab Ariel ESG ETF | 1.77% |
| LSEQ | Harbor Long-Short Equity ETF (LSEQ) | 1.45% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.42% |
| FHH.TO | First Trust AlphaDEX U.S. Health Care Sector Index ETF | 0.94% |
| FXH | First Trust Health Care AlphaDEX Fund | 0.94% |
| YUNG | Corgi ETF Trust I - Longevity Consumer ETF | 0.94% |
| XMVM | Invesco S&P MidCap Value with Momentum ETF | 0.92% |
| BRSM | MFS Blended Research Small-Mid Cap ETF | 0.65% |
| RFV | Invesco S&P MidCap 400 Pure Value ETF | 0.64% |
| DSMC | Distillate Small/Mid Cash Flow ETF | 0.51% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.50% |
| IHI | iShares U.S. Medical Devices ETF | 0.50% |
Weight is the stock’s share of each fund’s holdings.
